LENSAR, INC. Cash and Cash Equivalents
LENSAR, INC. (LNSR) had Cash and Cash Equivalents of $13.56 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $13.56M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $12.49M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $12.97M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $7.64M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $13.56M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $12.49M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $12.97M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $7.64M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $7.15M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $19.55M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $16.26M 10-K · filed 2026-03-31 |
| 2024-09-30 | $10.44M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $8.29M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $13.96M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $20.62M 10-K · filed 2025-02-27 |
| 2023-09-30 | $24.92M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $25.47M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $7.97M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $14.67M 10-K · filed 2024-03-04 |
| 2022-09-30 | $19.29M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $25.20M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $28.98M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $31.64M 10-K · filed 2023-03-16 |
| 2021-09-30 | $32.34M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $34.55M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $35.87M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $40.60M 10-K · filed 2022-03-03 |
| 2019-12-31 | $4.62M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |